News and Events

SOS is well known for it’s all-day cadaver labs providing ample time for attendees to get hands-on teaching and experience with many different oncoplastic techniques. This year, several exciting new technologies will be available in labs to learn and discuss how to integrate these tools into their practice.

Milestone indicates intraoperative radiation therapy (IORT) with electrons is gaining momentum as a treatment option for women with breast cancer SUNNYVALE, Calif. – IntraOp Medical Corporation today announced that more than 7,500 women with breast cancer have been treated with the IntraOp® Mobetron®, an intraoperative radiation therapy (IORT) device used to deliver a precise, cancer-killing … Continued

Dr. Zhu Xixu, Director of the Department of Radiation Oncology at NGH. “Electron IORT has demonstrated significant benefits in the treatment of locally advanced and recurrent cancers as well early stage breast cancer. The Mobetron expands our ability to treat these cancers and ensures our patients have access to the best possible treatment options to aid their fight against cancer.”

IntraOp Medical is proudly sponsoring the School of Oncoplastic Surgery Dallas January 22-24, 2016 Didactic lectures Full day cadaver lab Evening sculpture lab One on one with expert faculty Live models for surgical markings Enhance and learn new surgical skills Networking with faculty & colleagues Featuring new technologies in the lab Learn about coding for … Continued

The GEC-ESTRO Phase III trial validates the oncologic concept of APBI. The results of the GEC-ESTRO phase III trial comparing APBI versus WBI are significant and potentially practice changing in that they indicate for the first time (in a large, well-designed, contemporary phase III trial with adequate follow-up) that the scientific concept of treating only the lumpectomy cavity (plus a proper margin) is just as effective and safe as treating the whole breast in selected patients with early stage breast cancer.